Company news
Cambridge Cognition Holdings PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Circular Publication and Notice of General Meeting
May 31, 2024
Result of Placing and Subscription
May 30, 2024
Proposed Placing, Subscription and Open Offer
May 29, 2024
Preliminary Results, Trading Update & Board Change
May 1, 2024
COG spin-out Monument Therapeutics accesses £1.5m
April 23, 2024
Total Voting Rights and Block Listing Return
April 2, 2024
Formation of new Scientific Advisory Board
March 21, 2024
Cambridge Cognition and ActiGraph Partnership
February 21, 2024
Board appointments
January 30, 2024
Total Voting Rights
December 1, 2023
Automated quality assurance for clinical trials
October 24, 2023
Major contract win combining solutions
October 11, 2023
Issue of Warrants
October 5, 2023
Block listing Interim Review
October 3, 2023
Secured £3 million Term Loan
September 26, 2023
Notice of Interim Results
September 4, 2023
£2m contract for a pivotal cancer therapy trial
June 13, 2023
Notice of AGM – Revision to Explanatory Note
June 9, 2023
Capital Markets Day
May 31, 2023
Results for the year ended 31 December 2022
May 3, 2023
Investor Webinar and Analyst Briefing
April 26, 2023
£2.1 million contracts for rare disease trials
April 12, 2023
Block Admission Application & Exercise of Options
March 21, 2023
Acquisition of Winterlight Labs Inc
January 11, 2023
Strategic Partnership for Chinese Market Expansion
November 24, 2022
£1.1 million eCOA contract win
October 19, 2022
Acquisition of eClinicalHealth Limited
October 12, 2022
£2.2m neurodegenerative disease trial contract
September 1, 2022
Alzheimer's Disease Validation for NeuroVocalix
August 17, 2022
PTSD trials with top 10 pharma company & US DoD
July 28, 2022
Second Price Monitoring Extn
July 22, 2022
Trading Update and Notice of Results
July 21, 2022
Price Monitoring Extension
July 14, 2022
Results for the year ended 31 December 2021
April 12, 2022
Senior Management Appointments
April 6, 2022
£1 million contract for pivotal autoimmune trial
March 28, 2022
Appointment of Nominated Adviser and Joint Broker
March 24, 2022
£2.1 million contract
February 2, 2022
New Major Pharma Client for Schizophrenia Trials
January 10, 2022
Electronic Clinical Outcomes Assessment Contract
December 16, 2021
£1.0m Schizophrenia clinical trial contract
December 9, 2021
Contract for pivotal schizophrenia clinical trial
October 26, 2021
Cambridge Cognition wins contract for a pivotal schizophrenia trial
October 25, 2021
£1 million contract for late phase cancer trial
July 9, 2021
Spin-out of Monument Therapeutics
July 1, 2021
New £2.2 million contract
June 28, 2021
New £2.2 million contract for at-home cognitive testing in a virtual clinical trial
June 27, 2021
£1.4m of contracts for digital health & wearables
June 14, 2021
Brain Health Registry Cognitive Assessment Partner
June 11, 2021
Appointment of Executive Director
June 2, 2021
Calls
- Cambridge Cognition Holdings (LSE:COG) — Interim Results for the six months to 30 June 2026
Sep 16, 2026
Transcript - Cambridge Cognition Holdings (LSE:COG) — Results for the year ended 31 December 2025 Q&A Session
Apr 13, 2026
Transcript - Cambridge Cognition Holdings (LSE:COG) — 2025 Interim Results
Sep 3, 2025
Transcript - Cambridge Cognition Holdings (LSE:COG) — Preliminary Results
May 1, 2025
Transcript
Decks
- H1 2025 Earnings Presentation
Earnings · 13 slides · Sep 3, 2025
- FY2024 Earnings Presentation
Earnings · 15 slides · 2025